Xynomic Pharmaceuticals Holdings, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Xu Peixin, was filed 21 May 2019.
Xynomic Pharmaceuticals Holdings, Inc.: what insiders have been doing
Xynomic Pharmaceuticals Holdings, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). No insider at Xynomic Pharmaceuticals Holdings, Inc. has published a filing in the past twelve months. The most recent one dates from 21 May 2019.
Our records for Xynomic Pharmaceuticals Holdings, Inc. go back to 2017, with 5 purchases and no sales on the open market in total.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Financial data
as of FY 2019FY ended December 2019 · cache
- 108,980 sharesCommon Stock, par value $0.0001 per shareSEC:0001213900-19-009297:0Canonical exit: 13 Aug 2019 (T+90)
- 108,980 sharesCommon Stock, par value $0.0001 per shareSEC:0001213900-19-009295:0Canonical exit: 13 Aug 2019 (T+90)
- 39,375 sharesOrdinary share, no par valueSEC:0001213900-17-006912:0Canonical exit: 26 Sept 2017 (T+90)
- 39,375 sharesOrdinary share, no par valueSEC:0001213900-17-006914:0Canonical exit: 26 Sept 2017 (T+90)
- 39,375 sharesOrdinary share, no par valueSEC:0001213900-17-006910:0Canonical exit: 26 Sept 2017 (T+90)
5 of 5 declarations
About Xynomic Pharmaceuticals Holdings, Inc.
Xynomic Pharmaceuticals Holdings, Inc. is a company focused on developing innovative pharmaceutical treatments. It is listed on NASDAQ under the ticker XYN.
